Achieve Life Sciences, Inc. Financing Cash Flow
Achieve Life Sciences, Inc. (ACHV) reported Financing Cash Flow of $168.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-11
- Achieve Life Sciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $168.46M.
- Achieve Life Sciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $21.00K.
- Achieve Life Sciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $6.26M, a 818.33% increase year-over-year.
- Achieve Life Sciences, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $4.04M.
- Achieve Life Sciences, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $51.53M, a 6.18% increase from fiscal 2024.
- Achieve Life Sciences, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $48.53M, a 217.63% increase from fiscal 2023.
- Achieve Life Sciences, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $15.28M, a 20.90% decline from fiscal 2022.
- Achieve Life Sciences, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $19.32M, a 47.24% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $168.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $168.48M 10-Q · filed 2026-08-11 | $174.74M derived: sum of 3 quarters · filed 2026-08-11 | $178.78M derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | $21.00K 10-Q · filed 2026-05-12 | $6.28M derived: sum of 2 quarters · filed 2026-05-12 | $10.33M derived: sum of 3 quarters · filed 2026-05-12 | ||||
| 2025-12-31 | $6.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $10.30M derived: sum of 2 quarters · filed 2026-03-24 | $51.53M 10-K · filed 2026-03-24 | ||||
| 2025-09-30 | $4.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $45.26M 10-Q · filed 2025-11-06 | |||||
| 2025-06-30 | $41.22M 10-Q · filed 2026-08-11 | ||||||
| 2024-12-31 | $682.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | -$7.43M derived: sum of 2 quarters · filed 2026-03-24 | -$7.58M derived: sum of 3 quarters · filed 2026-03-24 | $48.53M 10-K · filed 2026-03-24 | |||
| 2024-09-30 | -$8.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$8.27M derived: sum of 2 quarters · filed 2025-11-06 | $47.84M 10-Q · filed 2025-11-06 | $47.84M derived: sum of 4 quarters · filed 2026-03-24 | |||
| 2024-06-30 | -$153.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $55.96M 10-Q · filed 2025-08-07 | $55.96M derived: sum of 3 quarters · filed 2026-03-24 | $55.96M derived: sum of 4 quarters · filed 2026-03-24 | |||
| 2024-03-31 | $56.11M 10-Q · filed 2025-05-13 | $56.11M derived: sum of 2 quarters · filed 2026-03-24 | $56.11M derived: sum of 3 quarters · filed 2026-03-24 | $71.34M derived: sum of 4 quarters · filed 2026-03-24 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $0.00 derived: sum of 2 quarters · filed 2026-03-24 | $15.23M derived: sum of 3 quarters · filed 2026-03-24 | $15.28M 10-K · filed 2026-03-24 | |||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $15.23M derived: sum of 2 quarters · filed 2024-11-07 | $15.28M 10-Q · filed 2024-11-07 | $32.99M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2023-06-30 | $15.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $15.28M 10-Q · filed 2024-08-13 | $32.99M derived: sum of 3 quarters · filed 2025-03-11 | $33.12M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2023-03-31 | $47.00K 10-Q · filed 2024-05-09 | $17.76M derived: sum of 2 quarters · filed 2025-03-11 | $17.89M derived: sum of 3 quarters · filed 2025-03-11 | $19.27M derived: sum of 4 quarters · filed 2025-03-11 | |||
| 2022-12-31 | $17.71M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $17.84M derived: sum of 2 quarters · filed 2025-03-11 | $19.22M derived: sum of 3 quarters · filed 2025-03-11 | $19.32M 10-K · filed 2025-03-11 | $19.30M 10-K · filed 2023-03-16 | ||
| 2022-09-30 | $126.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.51M derived: sum of 2 quarters · filed 2023-11-09 | $1.60M 10-Q · filed 2023-11-09 | $1.58M 10-Q · filed 2022-11-14 | $16.53M derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2022-06-30 | $1.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.48M 10-Q · filed 2023-08-14 | $1.46M 10-Q · filed 2022-08-11 | $16.40M derived: sum of 3 quarters · filed 2024-03-28 | $16.41M derived: sum of 4 quarters · filed 2024-03-28 | ||
| 2022-03-31 | $95.00K 10-Q · filed 2023-05-09 | $15.02M derived: sum of 2 quarters · filed 2024-03-28 | $15.03M derived: sum of 3 quarters · filed 2024-03-28 | $36.47M derived: sum of 4 quarters · filed 2024-03-28 | |||
| 2021-12-31 | $14.93M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $14.94M derived: sum of 2 quarters · filed 2024-03-28 | $36.37M derived: sum of 3 quarters · filed 2024-03-28 | $36.61M 10-K · filed 2024-03-28 | |||
| 2021-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $21.45M derived: sum of 2 quarters · filed 2022-11-14 | $21.68M 10-Q · filed 2022-11-14 | $37.62M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-06-30 | $21.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $21.67M 10-Q · filed 2022-08-11 | $37.61M derived: sum of 3 quarters · filed 2023-03-16 | $52.23M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-03-31 | $236.00K 10-Q · filed 2022-05-12 | $16.18M derived: sum of 2 quarters · filed 2023-03-16 | $30.80M derived: sum of 3 quarters · filed 2023-03-16 | $32.96M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2020-12-31 | $15.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $30.56M derived: sum of 2 quarters · filed 2023-03-16 | $32.73M derived: sum of 3 quarters · filed 2023-03-16 | $32.68M 10-K · filed 2023-03-16 | |||
| 2020-09-30 | $14.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $16.79M derived: sum of 2 quarters · filed 2021-11-09 | $16.74M 10-Q · filed 2021-11-09 | $29.44M derived: sum of 4 quarters · filed 2022-03-10 | |||
| 2020-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $2.12M 10-Q · filed 2021-08-12 | $14.82M derived: sum of 3 quarters · filed 2022-03-10 | $14.82M derived: sum of 4 quarters · filed 2022-03-10 | |||
| 2020-03-31 | -$47.00K 10-Q · filed 2021-05-13 | $12.66M derived: sum of 2 quarters · filed 2022-03-10 | $12.66M derived: sum of 3 quarters · filed 2022-03-10 | ||||
| 2019-12-31 | $12.70M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $12.70M derived: sum of 2 quarters · filed 2022-03-10 | $17.32M 10-K · filed 2022-03-10 | ||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $4.62M 10-Q · filed 2020-11-12 | |||||
| 2019-06-30 | $4.62M 10-Q · filed 2020-08-06 | ||||||
| 2018-12-31 | $5.01M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $5.86M derived: sum of 2 quarters · filed 2021-03-11 | $18.65M derived: sum of 3 quarters · filed 2021-03-11 | $19.76M 10-K · filed 2021-03-11 | |||
| 2018-09-30 | $846.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $13.64M derived: sum of 2 quarters · filed 2019-11-06 | $14.75M 10-Q · filed 2019-11-06 | $15.64M derived: sum of 4 quarters · filed 2020-03-13 | |||
| 2018-06-30 | $12.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $13.90M 10-Q · filed 2019-08-08 | $14.79M derived: sum of 3 quarters · filed 2020-03-13 | $15.88M derived: sum of 4 quarters · filed 2020-03-13 | |||
| 2018-03-31 | $1.10M 10-Q · filed 2019-05-15 | $2.00M derived: sum of 2 quarters · filed 2020-03-13 | $3.09M derived: sum of 3 quarters · filed 2020-03-13 | ||||
| 2017-12-31 | $894.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $1.98M derived: sum of 2 quarters · filed 2020-03-13 | $2.00M 10-K · filed 2020-03-13 | ||||
| 2017-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $1.11M 10-Q · filed 2018-11-07 | |||||
| 2017-06-30 | $20.00K 10-Q · filed 2018-08-08 | ||||||
| 2016-12-31 | $150.00K 10-K · filed 2019-03-14 | ||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $0.00 derived: sum of 2 quarters · filed 2014-03-11 | $0.00 derived: sum of 3 quarters · filed 2014-03-11 | $10.00K 10-K · filed 2014-03-11 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $10.00K 10-Q · filed 2013-11-07 | $12.00K derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $10.00K 10-Q · filed 2013-08-08 | $12.00K derived: sum of 3 quarters · filed 2014-03-11 | $358.00K derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2013-03-31 | $10.00K 10-Q · filed 2013-05-02 | $12.00K derived: sum of 2 quarters · filed 2014-03-11 | $358.00K derived: sum of 3 quarters · filed 2014-03-11 | $470.00K derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2012-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $348.00K derived: sum of 2 quarters · filed 2014-03-11 | $460.00K derived: sum of 3 quarters · filed 2014-03-11 | $54.24M 10-K · filed 2014-03-11 | |||
| 2012-09-30 | $346.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $458.00K derived: sum of 2 quarters · filed 2013-11-07 | $54.24M 10-Q · filed 2013-11-07 | $54.24M derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2012-06-30 | $112.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $53.89M 10-Q · filed 2013-08-08 | $53.90M derived: sum of 3 quarters · filed 2014-03-11 | $54.02M derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2012-03-31 | $53.78M 10-Q · filed 2013-05-02 | $53.78M derived: sum of 2 quarters · filed 2014-03-11 | $53.91M derived: sum of 3 quarters · filed 2014-03-11 | $53.91M derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2011-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $128.00K derived: sum of 2 quarters · filed 2014-03-11 | $128.00K derived: sum of 3 quarters · filed 2014-03-11 | $219.00K 10-K · filed 2014-03-11 | |||
| 2011-09-30 | $122.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $122.00K derived: sum of 2 quarters · filed 2012-11-08 | $213.00K 10-Q · filed 2012-11-08 | $47.02M derived: sum of 4 quarters · filed 2013-03-07 | |||
| 2011-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $91.00K 10-Q · filed 2012-08-02 | $46.90M derived: sum of 3 quarters · filed 2013-03-07 | $47.05M derived: sum of 4 quarters · filed 2013-03-07 | |||
| 2011-03-31 | $91.00K 10-Q · filed 2012-05-03 | $46.90M derived: sum of 2 quarters · filed 2013-03-07 | $47.05M derived: sum of 3 quarters · filed 2013-03-07 | ||||
| 2010-12-31 | $46.81M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $46.96M derived: sum of 2 quarters · filed 2013-03-07 | $47.48M 10-K · filed 2013-03-07 | ||||
| 2010-09-30 | $153.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $674.00K 10-Q · filed 2011-11-03 | |||||
| 2010-06-30 | $521.00K 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $17.35M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |